We also observed a significant increase in CCL20 secretion by IFNγ and TNFα treated CAFs, which has been implicated in regulatory T‐cell migration to the TME of NSCLC [22] and could therefore also have immunosuppressive consequences. The gene discussed is CCL20; the disease is non-small cell lung carcinoma.